检索

Stress-induced arterial hypertension

Ambatiello L.

(Rus)

卷 92, 编号 3 (2020)

Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world

Zakiev V., Gvozdeva A., Martynyuk T.

(Rus)

卷 92, 编号 9 (2020)

Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension

Aleevskaya A., Vyborov O., Gramovich V., Martynyuk T.

(Rus)

卷 93, 编号 3 (2021)

Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension

Taran I., Valieva Z., Belevskaya A., Saidova M., Martynyuk T., Chazova I.

(Rus)

Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry

Chazova I., Valieva Z., Nakonechnikov S., Taran I., Martynyuk T.

(Rus)

Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)

Oschepkova E., Aksenova A., Orlovsky A., Chazova I.

(Rus)

卷 90, 编号 9 (2018)

Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up

Glybochko P., Svetankova A., Rodionov A., Maltseva A., Sulimov V., Fomin V.

(Rus)

卷 90, 编号 1 (2018)

Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension

Simakova M., Ryzhkov A., Kazymly A., Naimushin A., Lukinov V., Moiseeva O.

(Rus)

卷 97, 编号 7 (2025)

Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry

Aksenova A., Serov I., Belova O., Rachkova S., Chazova I.

(Rus)

卷 93, 编号 1 (2021)

Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function

Falkovskaya A., Mordovin V., Pekarskiy S., Ripp T., Manukyan M., Lichikaki V., Zyubanova I., Sitkova E., Gusakova A., Ryabova T.

(Rus)

卷 91, 编号 3 (2019)

Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension

Sakhnova T., Blinova E., Belevskaya A., Saidova M., Arkhipova O., Yurasova E., Alokova F., Martynyuk T., Chazova I.

(Rus)

卷 97, 编号 3 (2025): Пульмонология

Historical milestones in the study of pulmonary hypertension

Osokina A., Rodnenkov O., Martynyuk T.

(Rus)

卷 95, 编号 4 (2023)

Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension

Shariya A., Martynyuk T., Shariya M., Ustyuzhanin D.

(Rus)

Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension

Podzolkov V., Safronova T., Natkina D.

(Rus)

卷 91, 编号 3 (2019)

Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension)

Chazova I., Lazareva N., Oshchepkova E.

(Rus)

卷 90, 编号 9 (2018)

Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension)

Oshchepkova E., Lazareva N., Chazova I.

(Rus)

卷 85, 编号 12 (2013)

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension

Tsareva N.

卷 92, 编号 9 (2020)

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

Gratsianskaya S., Valieva Z., Martynyuk T.

(Rus)

卷 91, 编号 12 (2019)

A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults

Shmalts A., Gorbachevsky S.

(Rus)

卷 79, 编号 9 (2004)

Arterial hypertension in chronic glomerulonephritis:detectability and treatment efficacy

Kutyrina I., Martynov S., Shvetsov M., Livshits N., Miroshnichenko N., Golitsina E., Varshavsky V.

卷 95, 编号 12 (2023)

Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review

Chazova I.

(Rus)

卷 91, 编号 1 (2019)

Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension)

Chazova I., Aksenova A., Oschepkova E.

(Rus)

Evidence base for specific pulmonary vasodilators in adults with congenital heart disease

Shmalts A., Gorbachevsky S.

(Rus)

卷 92, 编号 12 (2020)

Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia

Shmalts A., Gorbachevsky S.

(Rus)

Antihypertensive therapy in men and women in real clinical practice according to the National register

Oshhepkova E., Aksenova A., Orlovskij A., Chazova I.

(Rus)

卷 78, 编号 2 (2003)

Albarel (rilmenidin) - a selective agonist of imidazol receptors. II. Pharmacological properties and experience of clinical use

Khirmanov V.

Rehabilitation in patients with chronic thromboembolic pulmonary hypertension

Sagaydak O., Danilov N., Chazova I.

(Rus)

卷 94, 编号 1 (2022)

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension

Denisova A., Solntseva T., Zarmanbetova A., Tkacheva A., Sivakova O., Chazova I.

(Rus)

卷 90, 编号 3 (2018)

Combination therapy is a new standard for treatment of pulmonary arterial hypertension

Avdeev S., Tsareva N., Gaisin I.

(Rus)

New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension

Martynyuk T., Nakonechnikov S., Chazova I.

(Rus)

卷 87, 编号 1 (2015)

Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis

Volkov A., Kurmukov I., Iudkina N., Glukhova S., Nikolaeva E.

Pulmonary hypertension in Russia: The first results of the national register

Chazova I., Arkhipova O., Valieva Z., Nakonechnikov S., Martyniuk T.

卷 85, 编号 1 (2013)

Results of implementation of a hypertension control program in Russia in 2002-2012

Chazova I., Oshchepkova E.

卷 94, 编号 4 (2022)

A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report

Kasparova A., Valieva Z., Martynyuk T.

(Rus)

卷 84, 编号 4 (2012)

CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Avdeev S.

卷 96, 编号 1 (2024)

Therapies of chronic thromboembolic pulmonary hypertension: A review

Vasiltseva O., Edemskiy A., Zeinalov D., Kliver E., Ussov W., Grankin D., Sirota D., Chernyavskiy A.

(Rus)

卷 95, 编号 1 (2023)

Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy “escape” phenomenon

Mikhailova O., Elfimova E., Litvin A., Chazova I.

(Rus)

Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics

Valieva Z., Martynyuk T.

(Rus)

卷 93, 编号 12 (2021)

The assessment of renal function during the therapy of arterial hypertension with azilsartan medoxomil in patients with obesity or overweight and concomitant metabolic disorders

Nevzorova V., Petrichko T., Chazova I., Zhernakova J.

(Rus)

Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management

Aksenova A., Sivakova O., Blinova N., Danilov N., Elfimova E., Kisliak O., Litvin A., Oshchepkova E., Fomin V., Chikhladze N., Shelkova G., Chazova I.

(Rus)

卷 93, 编号 1 (2021)

Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders

Vasyuk Y., Dovzhenko T., Dubrovskaya T., Nesterova E., Shupenina E.

(Rus)

卷 92, 编号 12 (2020)

Detection of kidney dysfunction potential biomarkers with hypertension in the persons of 25–45 years

Kovalkova N., Khudyakova A., Kashtanova E., Polonskaya Y., Shcherbakova L., Ragino Y.

(Rus)

卷 92, 编号 5 (2020)

Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion

Маrtynuk T., Aleevskaya A., Gramovich V., Danilov N., Korobkova I., Matchin U., Solodovnikova L., Beketova T.

(Rus)

卷 91, 编号 12 (2019)

Evolution of pathogenetic therapy of pulmonary arterial hypertension

Chazova I., Yarovoy S., Danilov N.

(Rus)

Treatment of ARVI and influenza in patients with arterial hypertension

Silina E., Sitnikov I., Fazylov V., Yeganyan G.

(Rus)

卷 78, 编号 8 (2003)

How we treat patients withcardiovascular diseases in real clinical practice

Belenkov Y., Mareev V.

卷 91, 编号 1 (2019)

Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases

Grigoryeva N., Maiorova M., Korolyova M., Samolyuk M.

(Rus)

Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension

Mironchuk N., Amineva L., Mirsaeva G., Yunusova A.

(Rus)

卷 89, 编号 9 (2017)

A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?

Tsareva N., Avdeev S., Neklyudova G.

(Rus)

卷 89, 编号 3 (2017)

Hypertensive urgency or high blood pressure variability?

Rodionov A.

(Rus)

卷 88, 编号 9 (2016)

Occupational factors and a risk of cardiovascular diseases

Strizhakov L., Lebedeva M., Fomin V., Muhin N.

(Rus)

卷 88, 编号 8 (2016)

Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension

Sevostyanova E., Nikolaev Y., Bogdankevich N., Lusheva V., Markova E., Dolgova N.

(Rus)

卷 87, 编号 12 (2015)

Hypertension and cognitive impairments: Possible mechanisms of development, diagnosis, and approaches to therapy

Zueva I.

卷 87, 编号 4 (2015)

Specific features of hypertension in patients with systemic lupus erythematosus

Savina Z., Shilkina N.

Practical aspects of treatment in patients with chronic cerebral ischemia and hypertension in general somatic practice

Lebedeva M.

Molecular genetic markers of predisposition to thrombosis in adolescents with essential hypertension

Dolgikh V., Bol'shakova S., Kolesnikova L., Mikhalevich I.

卷 86, 编号 2 (2014)

Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis

Garbuzenko D.

卷 85, 编号 8 (2013)

Neyromidin in the treatment of Stage I hypertensive dyscirculatory encephalopathy

Maksimova M., Okhtova F., Sineva N., Vodop'ianov N.

卷 85, 编号 5 (2013)

Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension

Iskenderov B., Budagovskaia Z., Sisina O.

卷 84, 编号 12 (2012)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study

Martyniuk T., Konosova I., Chazova I.

卷 84, 编号 6 (2012)

ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE

Smirnov A., Petrischev N., Mnuskina M., Panina I., Pumyantsev A., Vasina E., Achkasova V., Menshutina M.

卷 83, 编号 12 (2011)

Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver

Mikheeva O., Drozdov V., Komisarenko I., Mikheeva O., Drozdov V., Komisarenko I.

卷 83, 编号 9 (2011)

High arterial rigidity is a significant but not obligatory factor of arterial hypertension in persons over 60 years of age

Boytsov S., Rogoza A., Kanishcheva E., Luk'yanov M., Boitsov S., Rogoza A., Kanischeva E., Lukianov M.

卷 83, 编号 4 (2011)

Changes in orthogonal ECG in hypertensive patients taking different antihypertensive therapy

Sakhnova T., Blinova E., Ryabykina G., Shutova L., Chikhladze N., Martynyuk T., Chazova I., Sakhnova T., Blinova E., Ryabykina G., Shutova L., Chikhladze N., Martynyuk T., Chazova I.

卷 82, 编号 9 (2010)

Psychological status of hypertensive patients consuming higher amounts of salt

Volkov V., Poselyugina O., Volkov V., Poselyugina O.

卷 81, 编号 10 (2009)

Essential hypertension, dementia, and antihypertensive therapy in geriatric patients

Kobalava Z., Kotovskaya Y., Tyul'kina E., Kobalava Z., Kotovskaya Y., Tyulkina E.

卷 81, 编号 9 (2009)

Risk of cardiovascular complications in patients with frequent hypertensive crises

Kolos I., Chazova I., Tereshchenko S., Nakonechnikov S., Kolos I., Chazova I., Tereschenko S., Nakonechnikov S.

卷 81, 编号 4 (2009)

Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity

Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P., Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P.

卷 80, 编号 2 (2008)

Features of combined (hbv/hcv-infection) viral lesion of the liver

Maev I., Nikushkina I., Samsonov A., Aksel'rod A.

卷 79, 编号 9 (2004)

Early diagnosis of renaldamage in hypertensive patients

Nanchikeeva M., Konechnaya E., Bulanov M., Gladkaya A., Kozlovskaya L.

卷 79, 编号 6 (2004)

Cerebrovascular complications in metabolic syndrome: possible approaches to a lower risk

Chazova I., Mychka V., Mamyrbaeva К., Gornostaev V., Dvoskina I., Sergienko V.

卷 79, 编号 1 (2004)

Diagnosis of disturbed lipid and carbohydrate metabolism in hypertensive women in outpatient setting

Polyatykina T., Al-sveirki A., Poltyrev V., Romanenko I., Budnikova N., Mishina I., Ivanova G.

卷 78, 编号 12 (2003)

The state of theleft ventricle of the heart and 24-h profile of arterial pressure in patients with effort angina and episodes of painlessmyocardial ischemia

Mazur E., Mazur V., Tkhind В., Omar I.

卷 78, 编号 3 (2003)

Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases

Arkhipova D., Kornev B., Popova E., Kogan E., Osipenko V., Privalova E., Kobylensky A., Mescheryakova S., Efremov E.

卷 78, 编号 1 (2003)

Effects of combined treatment ' with enalapril maleate and hypothiazide on structural-functional state of red cell membranes in hypertensive patients

Kuryata A., Geichenko V.

卷 95, 编号 9 (2023)

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review

Zakiev V., Kotovskaya Y., Tkacheva O.

(Rus)

卷 95, 编号 1 (2023)

Comorbid status of patients with hypertension

Osmanov E., Reshetnikov V., Manyakov R., Garaeva A., Korkmazova L., Demenkova V.

(Rus)

卷 94, 编号 3 (2022)

Comments on the article by Professor Dmitry D. Pletnev “Hypertension (the experience of analyzing its genesis)”

Baranova I.

(Rus)

卷 93, 编号 10 (2021)

Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy

Demidova T., Lobanova K., Perekhodov S., Antsiferov M., Oynotkinova O.

(Rus)

Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future

Martynyuk T., Chazova I.

(Rus)

卷 92, 编号 10 (2020)

Primary aldosteronism: The Mayo Clinic approach

Young W., Ladygina D., Balutina O., Beltsevich D.

(Rus)

Risk stratification methods and their significance in pulmonary arterial hypertension

Avdeev S., Tsareva N.

(Rus)

卷 91, 编号 4 (2019)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension

Danilov N., Matchin Y., Chernyavsky A., Edemsky A., Grankin D., Sagaydak O., Chazova I., Boytsov S., Karaskov A.

(Rus)

卷 90, 编号 9 (2018)

Features of the clinical picture in patients of middle age with essential hypertension

Parfenov V., Ostroumova T., Ostroumova O., Pavleyva E.

(Rus)

卷 90, 编号 1 (2018)

Stress in the family - association with prevalence of cardiovascular diseases in men of the open city population

Akimova E., Akimov M., Gakova E., Kayumova M., Gafarov V., Kuznetsov V.

(Rus)

Differences between passport and biological (actual) age in the population of Russian patients suffering from arterial hypertension (analysis of the «Hyperion» register)

Arutyunov A., Nozdrin A., Shavgulidze K., Tokmin D., Osadchiy I.

(Rus)

卷 89, 编号 8 (2017)

Bosentan use in pulmonary arterial hypertension: Russian and foreign experience

Valieva Z., Martynyuk T., Chazova I.

(Rus)

卷 89, 编号 3 (2017)

Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension

Moisseeva O., Rudakova A.

(Rus)

卷 88, 编号 12 (2016)

A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension

Arkhipova O., Martynyuk T., Chazova I.

(Rus)

卷 88, 编号 8 (2016)

Criteria for selecting patients with resistant hypertension for a renal sympathetic denervation

Ripp T., Rebrova T., Mordovin V., Afanasiev S., Pekarsky S., Semke G., Falkovskaya A., Lichikaki V., Tsymbalyuk E.

(Rus)

卷 87, 编号 11 (2015)

Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study

Volkov A., Nikolaeva E., Yudkina N., Kurmukov I., Nasonov E.

卷 87, 编号 3 (2015)

Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial)

Kobalava Z., Kotovskaya Y., Khodorovich N.

卷 86, 编号 8 (2014)

Neuroprotection in hypertensive patients: Minimization of poor prognosis

Shishkova V.

24-hour systolic wave increment index monitoring in patients with low-renin arterial hypertension

Valieva Z., Chikhladze N., Rogoza A., Iarovaia E., Bosykh E., Chazova I.

卷 86, 编号 1 (2014)

Association of leptin with obesity and hypertension in an ethnic Kyrgyz group

Kerimkulova A., Lunegova O., Mirrakhimov A., Alibaeva N., Neronova K., Baĭramukova A., Mirrakhimov É.

卷 85, 编号 9 (2013)

Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus

Statsenko M., Derevianchenko M., Ostrovskiĭ O., Titarenko M., Shvets M., Bondarev A.

卷 85, 编号 6 (2013)

Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)

Nagaĭtseva S., Shaliagin I., Shvetsov M., Piagaĭ N., Ivanova E., Shilov E.

卷 84, 编号 9 (2012)

Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy

Shostak N., Klimenko A., Novikov I., Demidova N., Aksenova A.

卷 84, 编号 4 (2012)

CHOICE OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION: SYMPTOMATIC AND BASIC, STANDARD AND SITUATIONAL

Gogin E.

卷 83, 编号 12 (2011)

Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction

Drapkina O., Ashikhmin Y., Drapkina O., Ashikhmin Y.

卷 83, 编号 5 (2011)

Efficacy of combined treatment of patients with severe obstructive sleep apnea and arterial hypertension of the second and third degree

Sukmarova Z., Litvin A., Chazova I., Rogoza A., Sukmarova Z., Litvin A., Chazova I., Rogoza A.

卷 83, 编号 4 (2011)

Microcirculatory disorders in hypertension, atherosclerosis, diabetes mellitus

Gogin E., Gogin E.

卷 82, 编号 6 (2010)

Calcium antagonists: on the way to expanding the indications

Fomin V.

卷 81, 编号 9 (2009)

Life devoted to cardiology. The 110 anniversary of professor a. l. Myasnikov's birth

Knopov M., Taranukha V., Knopov M., Taranukha V.

卷 81, 编号 8 (2009)

Renin as a target of direct pharmacological block in arterial hypertension

Mukhin N., Fomin V., Mukhin N., Fomin V.

卷 81, 编号 2 (2009)

Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus

Nestepov Y., Bondapeva I., Teplyakov A., Poltavtseva O., Nesterov Y., Bondareva I., Teplyakov A., Poltavtseva O.

卷 79, 编号 12 (2004)

Vasoregulating activity of the endothelium and pulmonary hypertension

Karoli N., Rebrov A.

卷 79, 编号 8 (2004)

Structure ofthe sinus dysfunction in hypertensive patients

Tuev A., Poteshkina N., Grigoriadi N.

卷 79, 编号 4 (2004)

Methodological approaches to estimation of a morning urge of arterial pressure in essential hypertensives

Lazareva N., Oschepkova E., Zelveyan P., Buniatyan M., Rogoza A.

卷 78, 编号 12 (2003)

Microalbuminuria: clinical and prognostic value in arterial hypertension

Arakelyants A., Zhukova N., Ryazanov A., Yurenev A.

卷 78, 编号 10 (2003)

Gestational arterial hypertension.Mechanisms of formation.Treatment with normodipin

Davidovich I., Bloschinskaya I., Petrichko T.

卷 78, 编号 3 (2003)

Clinical and functional assessment of daily blood pressure variations in patients with pneumonia

Geltser B., Kolelnikov V., Brodskaya T.

卷 78, 编号 1 (2003)

A 24-h arterial pressure profile in patients with arterial hypertension living in Tyumen North

Gapon L., Sereda T., Shurkevich N., Shanaurina N.

卷 95, 编号 9 (2023)

Five-year dynamics adrenergic reactivity of erythrocytes after radio-frequency sympathic denervation of renal arteries in patients with resistant arterial hypertension

Rebrova T., Falkovskaya A., Afanasiev S., Mordovin V., Zyubanova I., Muslimova E.

(Rus)

卷 94, 编号 9 (2022)

Features of vectorcardiograms in patients with hypertension complicated by chronic heart failure with reduced left ventricle ejection fraction

Sakhnova T., Blinova E., Yurasova E., Uskach T., Blinova N., Aidu E., Trunov V., Saidova M.

(Rus)

New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects

Dragomiretskaya N., Tarzimanova A., Kucherova J., Podzolkov V.

(Rus)

卷 93, 编号 6 (2021)

The state of cytokine regulation and endothelial dysfunction in the combined course of vibration disease and arterial hypertension

Babanov S., Baraeva R., Strizhakov L., Moiseev S., Fomin V.

(Rus)

卷 93, 编号 1 (2021)

Features of genetic manifestations in patients with abdominal obesity during atrial fibrillation in combination with arterial hypertension

Hidirova L., Yakhontov D., Maksimov V.

(Rus)

卷 92, 编号 10 (2020)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism

Dobreva E., Bibik E., Eremkina A., Ajnetdinova A., Nikankina L., Malysheva N., Mokrysheva N.

(Rus)

卷 92, 编号 3 (2020)

Exacerbation of idiopathic pulmonary fibrosis

Avdeev S., Gaynitdinova V., Merzhoeva Z., Neklyudova G., Tsareva N., Nuralieva G.

(Rus)

卷 81, 编号 1 (2009)

Genetic determinants of cardiovascular remodeling n Urbek patients with essential hypertension

Eliseeva M., Srozhidinova N., Khamidullaeva G., Abdullaeva G., Eliseeva M., Srozhidinova N., Khamidullaeva G., Abdullaeva G.

卷 90, 编号 10 (2018)

Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region

Kovaleva Y., Dreval A., Kulakov N., Fedorova S., Ilovayskaya I.

(Rus)

卷 90, 编号 1 (2018)

Cardiovascular disease and associated comorbid conditions as determinants of adverse perinatal outcomes in pregnancy - an analysis of the results of the register of pregnant BEREG

Stryuk R., Burns C., Filippov M., Brytkova Y., Borisov I., Barkova E., Gomova T., Kozina E., Nagirnyak O.

(Rus)

Pharmacotherapy of resistant arterial hypertension

Shepeleva N., Rodionov A., Fomin V.

(Rus)

卷 89, 编号 9 (2017)

Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome

Movsisyan G., Martynyuk T., Mershin K., Danilov N., Satybaldyeva M., Reshetnyak T., Akchurin R., Nasonov E., Chazova I.

(Rus)

卷 89, 编号 3 (2017)

Right ventricular diastolic function in patients with lung diseases in the absence or presence of pulmonary hypertension

Sumin A., Arkhipov O.

(Rus)

卷 88, 编号 9 (2016)

Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)

Chazova I., Martynyuk T.

(Rus)

卷 88, 编号 7 (2016)

The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension

Avdeev S.

(Rus)

卷 87, 编号 9 (2015)

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan

Avdeev S.

卷 87, 编号 4 (2015)

Cerebrovascular reactivity in patients with rheumatoid arthritis concurrent with and without hypertension

Rebrova N., Anisimova E., Sarkisova O., Mordovin V., Karpov R., Ripp T., Trifonova T., Bogomolova I.

Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril

Morozova T., Gontarenko S., Kuz'mina E.